Video

Brianna Norton, DO: Challenge with Co-Infected HCV, HIV Patients

Author(s):

Brianna Norton, DO, MPH, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY, talks about the challenges treating co-infected HIV and HCV patients.

Brianna Norton, DO, MPH, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx: Managing someone who's HIV, Hep. C co-infected, has become quite simple. Because even drug-drug interactions are very manageable. I think that the biggest challenge is probably getting them linked to Hep. C care. Now most of these folks who have HIV, are in HIV care and whether they're in it erratically or in it consistently, most people are. And so if we can get HIV docs, which I am, if we can get any HIV docs to really invest also in Hep C. care, rather than just send them to specialists. I think that we're not going to have huge barriers to getting HIV co-infected patients treated, and given the fact that they do worse, have rapid progression to liver fibrosis, it's going to be key to treat them. And it's so simple now, that really it's access more than anything.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.